tiprankstipranks
Trending News
More News >
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Nuvectis Pharma (NVCT) Income Statement

Compare
113 Followers

Nuvectis Pharma Income Statement

Last quarter (Q3 2025), Nuvectis Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Nuvectis Pharma's net income was $-7.46M. See Nuvectis Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 19.85M$ 22.90M$ 19.23M$ 12.89M$ 10.00K
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -19.00M$ -22.90M$ -19.23M$ -12.89M$ -10.00K
Operating Income
$ -19.85M$ -22.90M$ -19.23M$ -12.89M$ -10.00K
Other Income/Expenses
$ 847.00K$ 637.00K$ 149.00K$ 4.00K$ 0.00
Pretax Income
$ -19.00M$ -22.26M$ -19.09M$ -12.89M$ -10.00K
Net Income
$ -19.00M$ -22.26M$ -19.09M$ -12.89M$ -10.00K
Per Share Metrics
Basic EPS
$ -1.11$ -1.43$ -1.51$ -1.09$ 0.00
Diluted EPS
$ -1.11$ -1.43$ -1.51$ -1.09$ 0.00
Weighted Average Shares Outstanding
17.11M 15.56M 12.66M 12.72M 12.72M
Weighted Average Shares Outstanding (Diluted)
17.11M 15.56M 12.66M 12.72M 12.72M
Currency in USD

Nuvectis Pharma Earnings and Revenue History